Pfizer to end development of experimental obesity pill due to elevated liver enzymes
June 26, 2023 at 08:35 AM EDT
Pfizer's two pills are part of the same class of obesity drugs as Novo Nordisk's blockbuster weight loss injections Ozempic and Wegovy.
